The U.S. Food and Drug Administration has approved ChromaGen spectacle lenses to aid people with dyslexia and other reading disorders, according to a press release from ChromaGen Vision.
The company tested 150 students at Brighton School, in Baton Rouge, La., which specializes in dyslexia and dyslexia-related learning disabilties, according to the release. About 72% of the students “were prescribed ChromaGen lenses and saw an immediate increase in reading speed and accuracy and an improvement in handwriting,” the release said.
The patented technology, developed by David Harris, PhD, uses 16 different filtered lenses. “The lenses modify light’s wavelength as it passes into each eye, which dynamically balances the speed of the information traveling along the neurological pathways to the brain, according to the press release. “The result is that people are now seeing words and text that are clear and in focus and enjoy reading free of headaches, nausea and fatigue.”
A specially trained eye care practitioner tests each of the patient’s eyes individually to find the best combination of lenses.
April 1, 2013